News

Gladstone in the News June 2, 2020

Monster or Machine? A Profile of the Coronavirus at 6 Months

The New York Times—Melanie Ott, MD, PhD, director of the Gladstone Institute of Virology, is one of the virologists prominently featured in this detailed account of the COVID-19 pandemic and of scientists’ efforts to understand and fight the coronavirus.

Gladstone Experts COVID-19 Infectious Disease Ott Lab

Gladstone in the News May 31, 2020

Why Do Some People Refuse to Wear Masks? Defiance, Misguided Thinking

San Francisco Chronicle—Wearing a mask is increasingly mandated by businesses and local jurisdictions, but some people have refused to comply. Senior Investigator Warner Greene explains that since the coronavirus is spread by respiratory droplets, a mask is an extremely effective way to reduce transmission.

Gladstone Experts COVID-19 Infectious Disease Greene Lab

Gladstone in the News May 29, 2020

How Accurate Are Antibody Tests?

Deep Background with Noah Feldman—Alex Marson, director of the Gladstone-UCSF Institute of Genomic Immunology, shares the results of his lab's evaluation of currently available antibody tests for SARS-CoV-2 infection.

Gladstone Experts COVID-19 Genomic Immunology Marson Lab

Gladstone in the News May 29, 2020

Inspire Awards: Melanie Ott Leads Research into Biology of COVID-19

SF Business Times—Melanie Ott, director of the Gladstone Institute of Virology, was recently named one of the most influential women in Bay Area business by the San Francisco Business Times. She reflects on the similarities between the AIDS crisis and the current COVID-19 pandemic, and describes how her lab has refocused their efforts on the novel virus.

Gladstone Experts COVID-19 Infectious Disease Ott Lab

Gladstone in the News May 29, 2020

Inspire Awards: Jennifer Doudna Transforms UC Berkeley Lab to Process COVID-19 Tests

San Francisco Business Times—Early on in the pandemic, Gladstone Senior Investigator Jennifer Doudna, PhD, co-discoverer of CRISPR, recognized the need for safe, reliable, and rapid COVID-19 testing. She quickly mobilized a team of scientists from UC Berkeley, UC San Francisco, and elsewhere to develop a high-throughput detection assay and test vulnerable and at-risk populations in the Bay Area. Doudna was recently named one of the most influential women in Bay Area business by the San Francisco Business Times.

Womens Initiative Gladstone Experts COVID-19 Data Science and Biotechnology Doudna Lab

Video May 28, 2020

Finding Our Way Out: Gladstone’s COVID-19 Research

Get a deeper look at the most promising COVID-19 projects at Gladstone.

Gladstone Experts COVID-19

Gladstone in the News May 26, 2020

Bay Area Must Enable Economic, Equitable Recovery

San Francisco Chronicle—Katie Pollard, director of the Gladstone Institute of Data Science and Biotechnology, joined other Bay Area women scientists in an editorial on how the coronavirus pandemic has caused disproportionate challenges for women’s careers, and threatens to reinforce long-standing inequities in the STEM fields.

Womens Initiative COVID-19 Pollard Lab

Gladstone in the News May 24, 2020

Love in the Time of Coronavirus: How Families and Friends May Reunite

San Francisco Chronicle—Senior Investigator Warner Greene comments on how people can reduce risks when resuming get-togethers with friends or family.

Gladstone Experts COVID-19 Greene Lab

Gladstone in the News May 18, 2020

Combatting COVID-19 with Gladstone’s Warner Greene, MD, PhD

When Science Speaks Podcast—Senior Investigator Warner Greene shares his team’s plan to screen FDA-approved drugs to find those that could be repurposed to fight COVID-19.

Gladstone Experts COVID-19 Infectious Disease Greene Lab

Gladstone in the News May 18, 2020

Coronavirus: Trump Predicts Vaccine Delivery by End of 2020. Experts Say That’s Not Likely.

The Mercury News—Scientists are racing to develop and test vaccines to protect people against COVID-19, and clinical trials to determine the efficacy of one leading vaccine candidate are scheduled to begin in July. Melanie Ott, director of the Gladstone Institute of Virology, explained that vaccine development is a lengthy process, and the development of effective therapeutics may come before a vaccine is widely available.

Gladstone Experts COVID-19 Infectious Disease Ott Lab

Gladstone in the News May 14, 2020

A Minute of Talking Could Spray over 1,000 Droplets into the Air—Study

Inverse—A new study shows that speaking loudly can release droplets that contain coronavirus and have the potential to remain airborne for up to 14 minutes. Senior Investigator Warner Greene explains that any amount of the virus has the potential to cause infection.

Gladstone Experts COVID-19 Infectious Disease Greene Lab

Article May 13, 2020

Digging Deeper: COVID-19 Answers at the Cellular Level

Where do you look for answers to COVID-19? One team at Gladstone is analyzing patient samples at the cellular level for answers to inform patient care and prevention.

Gladstone Experts COVID-19 Infectious Disease Greene Lab Roan Lab

Article May 12, 2020

This Is Philanthropy’s Time: How Donors Are Providing Urgent Funding to End the Pandemic

As Gladstone scientists are moving to study COVID-19, urgent funding is needed to support their efforts.

Donor Stories COVID-19 Infectious Disease Ott Lab

Article May 12, 2020

Commuting to the Lab during a Pandemic: Meet the Scientists Who Are Studying COVID-19

While many are working from home, these scientists are continuing to go to the lab in hopes of making a discovery that could lead to the end of the COVID-19 pandemic.

Gladstone Experts Graduate Students and Postdocs COVID-19 Cardiovascular Disease Data Science and Biotechnology Infectious Disease Conklin Lab McDevitt Lab Ott Lab

Article May 8, 2020

Roddenberry Foundation Donates $1 Million to Support Gladstone COVID-19 Research

This generous gift will support Gladstone scientists who are pivoting their ongoing work to help fight the COVID-19 pandemic.

Donor Stories COVID-19 Roddenberry Stem Cell Center Srivastava Lab